profile report science to consumers, inc....profile report science to consumers, inc. otc:beut...

PROFILE REPORT

Science To Consumers, Inc. OTC:BEUTwww.sciencetoconsumers.com

Science To Consumers, Inc.Room 1618, American Bank Centre, 555 Ren Min Road, Guangzhou, China

Investor Relations [email protected]

CONTACT INFOApril, 2016

April, 2016

INDUSTRY Personal Products

STOCK SYMBOL BEUT

RECENT PRICE (APRIL 20TH) $0.48

SHARES OUTSTANDING 31,920,000

FISCAL YEAR ENDS May 31

STOCK INFO

Investment Highlights

Science To Consumers, Inc. (OTC: BEUT) brings the benefits of proven scientific breakthroughs in anti-aging bio-technology directly to the consumer. The company develops and markets a line of innovative, patent-protected personal care products. It brings to market a disruptive technology that revolutionizes the multibillion dollar anti-aging “cosmeceutical” industry.

The company was founded to capitalize on a portfolio of patents for innovative skin and hair care ingredients. It now has the exclusive license to develop and market skin and hair-care products.

Breakthrough in skin care

Science To Consumers’ anti-aging products contain a patented active ingredient, originally developed to treat combat wounds, that has shown remarkable success in diminishing existing wrinkles and preventing the emergence of new wrinkles as we age.

Revolutionary anti-aging cosmeceutical

With regular use, Dermalastyl brand anti-aging creams have shown better results against wrinkles than Botox® injections.

Huge market opportunity

The US anti-aging skincare market represents a $2 billion opportunity—and one product alone accounts for more than $100 million in sales each year.

Direct-to-consumer distribution

Dermalastyl has a loyal following of users, who have found the product despite the fact that it has had no formal marketing effort behind it, prior to the formation of Science To Consumers.

Science To Consumers, Inc.

OTC:BEUT

SCIENCE TO CONSUMERS, INC.

STOCK SYMBOL: OTC-BEUT

APR

IL 2

016

3

Science To Consumers, Inc.OTC:BEUT

ABOUT THE COMPANY

Science To Consumers, Inc. (OTC: BEUT) brings the benefits of proven scientific breakthroughs in anti-aging bio-technology directly to the consumer. The company develops and markets a line of innovative, patent-protected personal care products—like skin creams, eye serums, and facial scrub. You might be asking yourself, “How could a skin cream be patent-protected?” The answer to that question is a major reason we believe Science To Consumers brings to market a disruptive technology that revolutionizes the multibillion dollar anti-aging “cosmeceutical” industry.

Science To Consumers was founded to capitalize on a portfolio of patents for innovative skin and hair care ingredients. The company now has the exclusive license to develop and market skin and hair-care products that incorporate Elastatropin®

—a high-performance, genetically engineered biomaterial originally developed for use in treating severe wounds, like burns or combat injuries. Elastatropin is the Science To Consumers trade name for tropoelastin – a synthetic form of human tropoelastin.1 This is the natural precursor of elastin2—the highly elastic protein that enables certain human tissue to resume its shape after being stretched or contracted. If you pinch the skin on the back of your hand, it will bounce back to into place because of elastin. If, when you just pinched your skin, it did not snap back into place as quickly as it did when you were 20, then you’ve noticed that the skin loses elastin throughout the aging process. As elastin is steadily lost, skin begins to wrinkle and lose the appearance of tightness that it has in youth.



APR

IL 2

016

4

“Science To Consumers brings to market a disruptive technology”

AN ABSOLUTELY UNIQUE “ACTIVE” INGREDIENT

Tropoelastin is absolutely unique as an “active” ingredient in skin care products: unlike other so-called anti-aging compounds, it has been scientifically proven to have beneficial regenerative activity in living skin. A paper published in the prestigious, peer-reviewed journal, Advances in Wound Care, documents the ability of tropoelastin to accelerate the closing of wounds.3

The company’s flagship brand is the Dermalastyl® line of products—powered by Elastatropin. The product was introduced to a small, select market in 2005 and sold on a direct to consumer basis via the internet. With no significant advertising beyond word of mouth, Dermalastyl has generated almost $5 million in cumulative revenues on more than 30,000 separate transactions. The loyalty

consumers have shown to Dermalastyl, as well as the company’s own research studies (which we will cover in greater depth later in this report) show that Elastatropin helps restore the natural elastin content in skin. It prevents the onset of new wrinkles in human skin, and significantly reverses the wrinkling process with long term use.

Science To Consumers now controls the sale of the Dermalastyl line and the produce website, www.dermalastyl.com, and intends to aggressively market the product—maintaining the direct-to-consumer model—through online channels, telemarketing, and via televised infomercials. And the Dermalastyl line is just the beginning. Science To Consumers collaborates with Protein Genomics—the developers of Tropoelastin—in the research and development of new biomaterials to incorporate into personal care technologies. The company has an impressive product-development pipeline for future cosmetic, hair and eyelash growth preparations.



APR

IL 2

016

5

HOW SKIN AGES

There are two components to healthy, younger looking skin: elastin and collagen. Both are proteins. Elastin works to keep skin both flexible and tight. It stretches and retracts, enabling skin to bounce back when pulled. Elastin’s “stretch” also keeps the skin smooth4 and pliable, to accommodate activities like talking, eating or breathing deeply.5

Collagen is another type of protein—found in skin and connective tissues throughout the body. It helps skins stay supple and firm, while enabling the constant renewal of skin cells. As we age, both elastin and collagen levels decrease, and therefore the skin loses its firm appearance.

A number of anti-aging skin care products and treatments exist to boost collagen levels, but collagen is only one piece of the puzzle. Until Dermalastyl, there was no commercially available, non-prescription way to boost elastin.

Our bodies produce elastin for a relatively short time—generally, until we reach puberty.6 Once our bodies cease producing it, the elastin we do have begins to break down. This process increases considerably as we age—over the course of a typical lifetime, up to 10 percent of the total elastin in our bodies is lost. Aging also diminishes other proteins like laminin and keratin in addition to elastin and collagen, resulting in wrinkles, laugh lines, smile lines, crow’s feet and facial creases and sagging skin.7 As older adults, our skin becomes more susceptible to damage and requires more time to heal properly.

Imagine a child on a park bench with her mother and grandmother. Now, if the mother gently pinched the skin on the girl’s small hand, her skin would snap crisply back into place. On the older woman, that process might take several seconds. The quality and quantity of elastin accounts for that difference.



APR

IL 2

016

6

But why do we lose elastin?According to Smartskincare.com:

“Fibroblasts in older skin have a much reduced capacity to produce new elastin. This deficiency does not appear to be a result of the loss of fibroblasts or mutations in elastin-encoding genes. More likely, age-related changes in the skin’s biochemical environment shut down elastin production.”8

There are well known treatments to combat wrinkles like crow’s feet and facial creases as well as sagging skin, but all of these are temporary. According to the American Society of Plastic Surgeons (ASPS), facelifts and eyelid surgery are two of the five most common cosmetic surgeries. When you consider minimally invasive procedures, four of the top five address the appearance of skin. In 2013, the ASPS reported 6.3 million injections of Botulinum Toxin (more commonly Botox®). These injections relax facial muscles, diminishing the appearance of wrinkles. Soft Tissue Filler injections—like collagen—accounted for another 2.2 million procedures, all to recapture youthful appearance in the skin of the face.9

Of course surgical procedures—including minimally invasive ones—carry a degree of risk and expense that make them less than ideal ways to combat the visible signs of aging. What the researchers and genetic engineers behind Science To Consumers have achieved is an over the counter alternative to many of these procedures—not to mention ineffective cosmetics products—using advanced science to reintroduce a substance your body once created naturally.

SCIENTIFIC BREAKTHROUGH: Elastatropin™ (Tropoelastin)

Elastatropin™ (Tropoelastin)—a key active ingredient in Dermalastyl—was originally synthesized under a Defense Advanced Research Projects Agency (DARPA) competition to synthesize human skin to allow for scarless healing of war wounds. 10 The goal was to promote tissue regeneration to help treat battlefield injuries, and it was successful. Now patented by Protein Genomics—a biomedical research and development company led by two of the founders of Science To Consumers—Tropoelastin has proven its worth in stimulating healing. The same action that makes it a powerful medicine also makes it a powerful cosmeceutical compound.

Tropoelastin works because it is able to move through the surface of the skin and penetrate down to the region where new skin is made—which sounds easier than it is. The primary function of skin—which is your body’s largest organ—is to act as a barrier. Skin protects us from injury from impacts, pressure and friction, as well as from exposure to harmful organisms or chemicals. It also protects us from thermal variations. It regulates body temperature by producing perspiration and dilating or contracting tiny blood vessels near the surface. It also produces Vitamin D and, of course, provides sensation. It is our organ of touch. Different nerve cells and networks in the skin tell us when we are too hot or cold, when we are in pain, and when we come into contact with other things. The wounds that motivated DARPA’s competition have a profound impact on all of skin’s physiological functions.11

“Until Dermalastyl, there was no commercially available, non-prescription way to boost elastin. ”



APR

IL 2

016

7

Your skin is composed of layers of layers. Most of us are familiar with the major layers: the dermis and the epidermis. The epidermis—the outer layer of skin—is itself composed of various strata. The actual surface of our skin is the stratum corneum. It is the wall, so to speak, between us and the world outside of our skin. As a barrier, it is effective, preventing water from leaving our skin, but it is also a barrier to introducing certain skincare ingredients—a barrier Elastatropin overcomes. It is under the stratum corneum where the epidermis is constantly regenerated with new skin cells created in the dermis. Tropoelastin’s natural composition enables it to move freely through the skin’s many layers. By taking advantage of this property, Protein Genomics discovered a means to introduce a source of elastin from outside the body. The discovery of Elastatropin means human elastin can be now be used as component of anti-aging skincare products or anti-wrinkle creams.

ELASTATROPIN CHANGES THE SKIN CARE GAME

Using a complex chain of 600 amino acids in a patented molecular delivery system, Elastatropin enters into the outer skin layers, moving into the epidermis, where it converts into elastin and integrates itself, cross-linking with existing elastin and other proteins. The ability of human tropoelastin to penetrate living human skin was verified in collaboration with dermatologists in a study at Thomas Jefferson University.12

In addition to the physiological functions, the skin—especially of the face—tends to show our age, and this can have a profound effect on people’s confidence and sense of physical attractiveness. In 2013, Americans spent more than $2 billion on anti-aging skin care products, and one facial anti-aging brand alone, Olay Regenerist (owned by Procter and Gamble) had sales of more than $103 million.13



APR

IL 2

016

8

“Benefits verified in collaboration with dermatologists in a study at Thomas Jefferson University”

Regenerist’s anti-aging claims rest on amino peptides—short chains of amino acids14 (and far fewer of them than Dermalastyl uses, by the way15). These amino peptides do improve collagen16, while moisturizing the skin to produce a younger, less wrinkled appearance—but it, and as far as our research has shown, and all other retail over the counter antiaging lotions, serums, or other topicals, do nothing to improve or stimulate production of elastin.

Elastatropin might be the ingredient that turns the anti-aging skin care market on its head:

• It is bioavailable, which means it can easily be absorbed and used by the body

• It is genetically compatible with human skin and actually integrates into the extracellular matrix to form elastin

• Its proteins are natural and identical to the human material, despite having been synthesized in a laboratory

• Both dermatological research and clinical trials support the effectiveness of Elastatropin™ as a vehicle to safe and healthy skin rejuvenation.



APR

IL 2

016

9

DERMALASTYL: THE FLAGSHIP BRAND

Science To Consumers is an early stage company, but unlike the typical young enterprise, it is entering the market with a proven product line—one with an intensely loyal following. That loyalty has created more than 5 million in revenue for a product that has had no marketing beyond word of mouth (the original form of viral marketing). The company’s website features many referrals. Here is just one, and its shows a great deal about the powerful, successful results Dermalastyl offers users:

“I ran into someone I know that hadn’t seen me in a few months and she couldn’t stop raving about my skin. I told her about your product.”

Carol,Merrick, NY

Keep in mind that the Dermalastyl brand achieved this success in a marketing vacuum. It was entirely unheralded and unknown. Its target market found the product, not the other way around. This is because Protein Genomics is a research and development firm—not a retailer. That Dermalastyl achieved commercial recognition is one of those things that is not supposed to happen in business: Protein Genomics made no investment in marketing Dermalastyl, other than to construct an e-commerce product website. This is one case in which, when they built a better mousetrap, the world did start to beat a path to its door. Even the media is spreading the word—visit the company’s website, and you’ll find television news coverage and glowing articles from newspapers like the Tampa Bay Times.17

THE DERMALASTYL DIFFERENCE

Dermalastyl-β is essentially a quick-absorbing anti-wrinkle cream that users apply in small amounts to the face and neck, twice a day, to enhance elastin and collagen production. Remember that Dermalastyl’s difference is that it not only reduces the appearance of existing wrinkles within a few weeks of use, it also prevents the emergence of new wrinkles when used over several months. As the body begins to repair and regenerate elastin and collagen, users see improvements in both firmness and tone. Sustained use provides exceptional resistance to photo damage caused by sun exposure. The product is applied before cosmetics, moisturizer or sun blocker. The eye serum formulation is more concentrated to combat the fine lines and drooping that often occurs. The Dermalastyl-βx Pro formula contains five times the amount of tropoelastin as regular-strength Dermalastyl. While results vary by individual, the company’s research shows that one year of continuous Pro formula use provides six times the amount of elastin lost over a typical five-year period.



APR

IL 2

016

10

SUBSTANTIATING THE CLAIMS

Topical skincare products do not require FDA approval, but the company has put Dermalastyl through rigorous claim substantiation testing, which is the typical testing protocol for the skincare product industry. As you might expect for a company founded by scientists, the product line has undergone complete safety and efficacy testing, using profilometry, the “gold standard” analytical methods, to measure the results. Thirty-two subjects used Dermalastyl cream for 12 weeks, and the results we remarkable: Dermalastyl was more effective than the prescription products Botox™, Tritinoin™ and Estrogen in reducing the depth and volume of wrinkles in the crow’s feet area of the face.

The subjects achieved an average:

• 33% decrease in wrinkle density

• 23% decrease in the volume of wrinkles

• 20% decrease in the depth of wrinkles

Trials also confirmed how quickly the product works, showing that skin can absorb Elastatropin within 24 hours. This documented biological activity, demonstrated in peer-reviewed preclinical studies18 , is significant differentiator. The “active” ingredients in many other anti-aging creams are plant or marine extracts, which are biologically

inert—meaning they do not stimulate the body’s development of natural proteins. Dermalastyl might be the only non-prescription, commercially available skin care products available that contain an active ingredient with scientifically proven clinical potential. Simply put, Dermalastyl offers a bio-active, natural remedy for wrinkles, without cost the discomfort, downtime and risks typically involved in cosmetic surgery, injections or resurfacing.

PATENTED IP

While elastin is a natural substance, Elastatropin (Tropoelastin) is the product of genetic engineering, which means it can be protected with patents. Protein Genomics holds four issued and two pending patents for their work in this area, including those that make the use of tropoelastin in cosmetic preparations impossible for other companies to precisely duplicate. Science To Consumers has an exclusive license for dermatological and cosmetic applications of the patents. Not only that, but any additional or pending patent filings that are applicable to Science To Consumers’ mission will be covered under the existing license agreement, which means future products will likely enjoy a similar level of patent protection as Dermalastyl does. Clearly, this is a major benefit to the company’s outlook.

PATENT/CASE # Date Issued/Filed Inventors Title

5,726,040 March 10, 1998B. EnsleyM. Ludmer

Cosmetic compositions including tropoelastin isomorphs

6,451,326 Sept 17, 2002 B Ensley Cosmetic compositions

6,572,845 June 3, 2003 B. Ensley Recombinant hair treatment compositions

6,808,707 October 26, 2004 B. EnsleyWound healing compositions and methods using tropoelastin and lysyl oxidase

20080038243 February 14, 2008 B. Ensley Wound healing

20110158924 June 30, 2011M. Dickman B. Ensley

Photo-Protective dermatological formulations



APR

IL 2

016

11

THE GOAL: A STEADY STREAM OF INNOVATIVE PRODUCTS

Science To Consumers, in collaboration with Protein Genomics, maintains a proprietary database of tropoelastin genetic variants which have become the subject of additional patent filings. The library represents a resource for further formulations and designs of skin care ingredients. For the first time, the performance of skin care products can be correlated with a genetic background, enabling Science To Consumers to formulate products for specific ethnic or demographic groups such as Latinos, Asians or Eastern Europeans, giving it yet another unique competitive advantage.

SKIN CARE AND ANTI AGING MARKET

Science to Consumers is hitting the skincare and anti-aging market at the right time and with the right model to take advantage of global and national trends. Globally, the size of the skincare market is huge—estimated to exceed $120 billion in 2016. In the US, the skincare market is growing at a faster rate than the overall market19, propelled by demographic changes that bode well for a product like Dermalastyl—which is purchased and used regularly over a long period by customers who see results.

As Statista.com points out in a recent article:

“Anti-aging products also represent a strong growth area in the US cosmetics and toiletries market. In 2014, the leading skin care brand in the United States was Olay Regenerist, an anti-aging brand that is owned by Procter & Gamble, with sales that amounted to approximately 103 million U.S. dollars. . . the U.S. anti-aging skin care market generated about 2.11 billion U.S. dollars in 2013.”20

MILLENNIALS: A MAJOR CONSUMER FORCE IN ANTI-AGING SKIN CARE

The growth in anti-aging skincare is coming from two directions: Baby Boomers and their children—the Millennial generation. The US Millennial generation accounts for 87 million people. Just how old are the Millennials? According to Pew Research, they will be 18-35 years old in 2015. Baby Boomers—now entering retirement years—boast another 76 million.21 Boomers will be between the ages of 51 and 69 in 2015.22

Dermatologist are seeing unprecedented numbers of people—mostly women—seeking to prevent the signs of aging before they begin—which is one of Dermalastyl’s primary benefits. Marketwatch reports that “In 2012, for instance, nearly 489,000 botulinum toxin injections were administered to patients ages 19 to 34; up from roughly 220,000 in 2002, according to the American Society for Aesthetic Plastic Surgery.”23

Regardless of their age, women in the US are concerned about signs of aging on the face especially. In a national study of women between 21 and 65, nearly 60% of respondent wanted a youthful looking face more than a youthful looking body. A larger group, 64 percent, reported noticing the shape of their face has changed with age.24

vva

PLANNED FUTURE APPLICATIONSOF ELASTATROPIN

• Eyelash Enhancing Serum

• Hair growth product

• Stem-cell based products

• Ethnically-oriented products



APR

IL 2

016

12

“Globally, the size of the skincare marketis huge—estimated to exceed

$120 billion in 2016.”

It seems that women worldwide share the concerns of women in the US. Industry trend watchers at GCI Magazine tell us that women are embracing new technologies to improve their appearance:

Women worldwide are falling out of love with, and moving away from, the cosmetic beauty model. They are willing to experiment with alternatives that they believe can deliver dramatic improvements to their skin condition and appearance. . . . Wellness and technological beauty are already impacting on what many people want from their products, making even the most conservative of beauty consumers more open than ever to new skin care technologies and formulations.25

Canadean Research studied consumer behavior in 10 emerging and mature economies and found that “nearly $44 billion was spent on skin care products in 2012; almost $39 billion of this was on Body Care and Facial Care products. Anti-aging is a big feature of these categories — categories where consumer data shows that those aged 25 and over accounted for almost two-thirds of total consumption.”26

The Asia Pacific region owns the largest share of the global skin care market, followed by Europe and North America. In Europe and North America, anti-aging cream is leading the market for skin care products, while brightening creams lead in Asia Pacific, followed by anti-aging creams.27

SALES AND DISTRIBUTION

Science To Consumers plans to take advantage of a huge and growing trend: ecommerce. US ecommerce has grown at a pace at least twice as fast as total retail sales, and that trend will continue28. Ecommerce sales climbed 16 percent during 2011, 14% in 2012 and 2013 29, and are predicted to reach $429 billion by 2015.30 The company’s e-commerce model will create, leverage and monetize loyalty to the site.

By controlling product distribution, Science To Consumers protects its margins and controls its own growth—not to mention new product introduction. The company’s existing e-commerce sites, as well as fulfillment centers currently distributing product, position Science To Consumers to realize significant sales with a low cost-high-return media buy campaign. The campaign will utilize existing and past customers, low cost high return radio and TV ads, and targeted infomercials directing customers to a toll-free call center or the product website. Dermalastyl buyers will be a “captive” audience for new products that will be launched and marketed on the e-commerce sites as well.

The company offers a “Preferred Customer” status under which the customer subscribes to automatic shipments of product in exchange for rewards like discounts or free products.

THE SALES OUTLOOK

Science to Consumers projects steep growth, from $3.8 million in 2016 to more than $28 million by 2018.

Glo

bal A

ntia

ging

Mar

ket

($B

illio

ns)

600

500

400

300

200

2006 2009 2013 2016 2030

100

0

TRENDS: Global Antiaging Market ($Billions)

Source: BCC Research 2009 & Global Industry Analyst



APR

IL 2

016

13

COMPETITION

The majority of so-called anti-aging creams are predominantly low-cost moisturizer based products with limited benefits.31 Science To Consumers does not consider these products as competitors. Instead, Dermalastyl will compete with “prestige” labels. These prestige products come with a prestige price tag. For example, Este Lauder’s Re-Nutriv brand retails for about $80 per 1.7-oz. jar or Creme de la Mer, which can cost the same amount for a 0.5 –oz jar.32

The company’s main competitors are prestige brands from companies that have built success with new skincare technology, including Olay Regenerist, which has the largest market share

in the category, at 3%. This product has been rated the best performing product by independent analysts and offers a line of products including facial moisturizers, specialty treatments and facial cleansers all dedicated to correcting the damages to the skin caused by aging. PerriconeMD, one of the first doctor-developed skin care brands, is another such product. Perricone formulates a high potency (HP) professional line and a retail line. Products like Olay Regenerist and Perricone are widely available online, through television shopping networks like QVC, and at high-end retail stores.We see the company’s competition as providing a ready market for Dermalastyl. People who routinely purchase these products are clearly looking for a solution that works, and will pay for it time and time again.



APR

IL 2

016

14

KEY EXECUTIVES

Burt Ensley, Ph.D.

Chairman and CEO

Dr. Burt Ensley is a pioneer in the field of genetic research. His professional career began in 1981 when he started with Amgen Inc., a start-up biotech firm in Thousand Oaks, California, and he assisted them in becoming the largest such biotech company in the world within ten years. Dr. Ensley holds his Ph.D. in microbiology from the University of Georgia (1979) and his master’s degree in biology from the University of New Mexico (1976). Dr. Ensley has 30 publications in peer-reviewed scientific literature and holds 19 issued and 2 pending US patents relating to his field of biology. Dr. Ensley has been involved in several early-stage biotech companies, including Envirogen, Phytotech and NuCycle Therapy, Inc. and he is the developer and patent-holder of tropoelastin and cosmetic compositions including tropoelastin. Dr. Ensley was elected to the Fellowship in the American Academy of Microbiology in recognition of his research accomplishments. He is an Adjunct Professor at Northern Arizona University.

His affiliations are numerous and some highlights are:

• Board of Directors and Co-Chair of the B105 Institute at the University of Arizona

• Advisory Committee National Science Foundation

• Board of Trustees at the Biotechnology Council of New Jersey

• Board of Directors of the National History Museum at the University of Kansas

James Janis

President

Jim Janis has an extensive background in public relations/marketing. For the past 25 years he has managed more than 200 clients, the majority being emerging growth public companies. He has been involved in the raising of equity, introducing companies to the financial community, and creating awareness of public companies.

Doug Franke

Senior Executive Advisory Director/Direct Marketing

Doug Frankel was involved in the early adoption of direct-to-consumer marketing. He mastered his media buying skills of while representing Pro Active skin Care. One of the innovative approaches he brings to S2C is his belief in rigorous and detailed testing and analysis of the advertising message and response. This approach reduces costly advertising failures and is responsible for his success in the past with many start-up companies; helping some of them grow their revenues to more than $30 million.



APR

IL 2

016

15

RISKS AND UNCERTAINTIES

The key risk to Science To Consumers’ growth strategy is the regulatory environment. Given the nature of the product, formulation, manufacturing, processing, packaging, labeling, advertising, distribution are subject to regulation by a number of federal, state and foreign agencies, principally, the Food and Drug Administration and the Federal Trade Commission.

The company operates well within existing regulatory guidelines with regard to the health claims of the products. However, when a new technology enters and established market—it is possible that the regulatory environment may change.

The science behind Dermalastyl has been proven and the consumer experience agrees: this product delivers the benefits claimed by the company, so we would not expect this to be a significant threat to the existing product line.

CONCLUSION

Based on our research, BEUT is a stock to buy now. We believe Science To Consumers is poised for rapid success. As we’ve seen, the leading prestige anti-aging brand generates more than $100 million with a 3% market share. If the company can achieve only a portion of that market share, then it will shatter its conservative sales estimates—and what’s to stop it? The product is truly revolutionary, promising the benefits of leading anti-aging creams and serums, plus something no one else can begin to claim: the regeneration of elastin in human skin. Its distribution model puts the company in precise control of expansion, and positions it to introduce new patent protected products to loyal Dermalastyl users. When the world learns about Dermalastyl—as it surely will from the multi-pronged media campaign planned by the company—this stock could quickly soar to dizzying heights. But only those who jump in before Dermalastyl becomes the next big name in the anti-aging skin care will reap the full rewards and tremendous returns that BEUT could offer.



APR

IL 2

016

16

Sources

1. http://www.researchgate.net/profile/Anthony_Weiss2/publication/227846668_Biochemistry_of_tropoelastin/links/544f8e560cf2bca5ce92a5ad.pdf

2. http://www.jbc.org/content/255/1/100.full.pdf

3. http://www.sciencetoconsumers.com/media/Machula%20et%20al,%202014%20(Advances%20in%20Wound%20Care).pdf

4. http://www.livestrong.com/article/221970-collagen-elastin-in-the-skin/

5. http://www.wisegeek.org/what-is-elastin.htm

6. http://www.medicinenet.com/script/main/art.asp?articlekey=24541

7. https://www.consumerhealthdigest.com/wrinkle-care/what-is-elastin.html

8. http://www.smartskincare.com/skinbiology/skinbiology_elastin.html

9. http://time.com/10334/here-are-the-most-popular-plastic-surgery-procedures-in-three-charts/

10. http://mediasyndicate.com/Article17691.phtml

11. http://www.clinimed.co.uk/Wound-Care/Education/Wound-Essentials/Structure-and-Function-of-the-Skin.aspx

12. http://globenewswire.com/news-release/2005/08/23/332104/84407/en/Prevent-Wrinkles-Dermaplus-Inc-Says-Yes-It-Can-Arizona-Professor-Claims-to-Find-Holy-Grail-of-Skin-Care.html

13. http://www.statista.com/statistics/254612/global-skin-care-market-size/

14. http://www.olay.com/en-us/skin-care-products/regenerist-micro-sculpting-cream-moisturizer

15. http://globenewswire.com/news-release/2005/08/23/332104/84407/en/Prevent-Wrinkles-Dermaplus-Inc-Says-Yes-It-Can-Arizona-Professor-Claims-to-Find-Holy-Grail-of-Skin-Care.html

16. http://www.examiner.com/article/skin-care-101-what-are-peptides-peptides-proteins-and-collagen

17. http://www.tampabay.com/news/aging/lifetimes/magnifying-mirror-on-the-way-whos-the-fairest-of-them-all/1271643

18. http://www.sciencetoconsumers.com/media/Machula%20et%20al,%202014%20(Advances%20in%20Wound%20Care).pdf



21. http://money.cnn.com/interactive/economy/diversity-millennials-boomers/

22. http://www.pewresearch.org/fact-tank/2015/01/16/this-year-millennials-will-overtake-baby-boomers/

23. http://www.marketwatch.com/story/10-things-the-anti-aging-industry-wont-tell-you-2014-02-11?page=1

24. http://www.gcimagazine.com/marketstrends/segments/antiaging/Women-Want-Youthful-Face-More-Than-Youthful-Body-282289931.html

25. http://www.gcimagazine.com/marketstrends/segments/skincare/Beauty-in-Transition-2015-2025-285978941.html

26. http://www.cosmeticsdesign.com/Market-Trends/Products-targeting-prevention-offer-big-opportunity-in-anti-aging-market

27. http://www.prnewswire.com/news-releases/skin-care-products-market---global-industry-analysis-size-share-growth-trends-and-forecast-2014---2020-300070361.html

28. http://www.practicalecommerce.com/articles/4017-Ecommerce-Trends-Point-to-Bright-Future

29. http://www.businessinsider.com/us-e-commerce-growth-is-now-far-outpacing-overall-retail-sales-2014-4

30. http://www.firstdata.com/downloads/thought-leadership/enhancing-eCommerce-WP.pdf

31. http://www.patentinsightpro.com/techreports/1110/Technology%20Insight%20Report-%20Anti-Aging%20Skin%20Care%20Compounds.pdf

32. http://www.nutraceuticalsworld.com/contents/view_features/2009-09-01/anti-aging-fuels-the-cosmeceuticals-boom#sthash.5gYW6ohz.dpuf



APR

IL 2

016

17

Disclaimer

Analyst Certification

Smallcapsociety.com (“SCS”) hereby certifies that the view expressed in this research report accurately reflects SCS’s personal views about the subject securities and issuers. SCS also certifies that no part of SCS’s compensation was, is, or will be, directly or indirectly, related to the recommendations or views expressed in this research report.

Disclaimer

This Profile Report on Science to Consumers Inc. (the “Company”) was prepared for informational purposes only. Smallcapsociety.com (“SCS”) produces research via Profile Reports. Updates and articles reflect sponsored (paid) research but can also include non-sponsored micro-cap research ideas that typically carry significant risk. Research on stocks in Profile Reports have a high risk profile, and may offer greater upside. SCS has been compensated $5,000 by a third party for this Profile Report.

This Profile Report is the opinion of SCS. The Company has not endorsed or compensated SCS for this article. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.

The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. SCS did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other sources of publicly available information. SCS relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. An SCS report, update, article, or note is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.

This publication does not take into account the investment objectives, financial situation, or particular needs of any particular person. This report does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither SCS nor its principals, analysts, employees or associates is registered as a securities broker-dealer or an investment adviser with FINRA, the U.S. Securities and Exchange Commission or with any state securities regulatory authority. Neither SCS nor its analysts, principals, associates and employees own shares in the Company.

ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, SCS WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, SCS WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.

Reprinting, reproduction, or copying of this Profile Report or any material contained herein is strictly prohibited.

profile report science to consumers, inc....profile report science to consumers, inc. otc:beut...

Documents